IBDEI12Q ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18951,2)
 ;;=Tonsillitis, Acute^2695
 ;;^UTILITY(U,$J,358.3,18952,0)
 ;;=465.9^^105^1225^46
 ;;^UTILITY(U,$J,358.3,18952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18952,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,18952,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,18952,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,18953,0)
 ;;=386.11^^105^1225^4
 ;;^UTILITY(U,$J,358.3,18953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18953,1,4,0)
 ;;=4^386.11
 ;;^UTILITY(U,$J,358.3,18953,1,5,0)
 ;;=5^Benign Parxysmal Vertigo
 ;;^UTILITY(U,$J,358.3,18953,2)
 ;;=^269480
 ;;^UTILITY(U,$J,358.3,18954,0)
 ;;=780.4^^105^1225^47
 ;;^UTILITY(U,$J,358.3,18954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18954,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,18954,1,5,0)
 ;;=5^Vertigo
 ;;^UTILITY(U,$J,358.3,18954,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,18955,0)
 ;;=784.8^^105^1225^5
 ;;^UTILITY(U,$J,358.3,18955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18955,1,4,0)
 ;;=4^784.8
 ;;^UTILITY(U,$J,358.3,18955,1,5,0)
 ;;=5^Bleeding From Throat
 ;;^UTILITY(U,$J,358.3,18955,2)
 ;;=^273371
 ;;^UTILITY(U,$J,358.3,18956,0)
 ;;=373.00^^105^1225^6
 ;;^UTILITY(U,$J,358.3,18956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18956,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,18956,1,5,0)
 ;;=5^Blepharitis NOS
 ;;^UTILITY(U,$J,358.3,18956,2)
 ;;=^15271
 ;;^UTILITY(U,$J,358.3,18957,0)
 ;;=528.2^^105^1225^8
 ;;^UTILITY(U,$J,358.3,18957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18957,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,18957,1,5,0)
 ;;=5^Canker Sore
 ;;^UTILITY(U,$J,358.3,18957,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,18958,0)
 ;;=112.0^^105^1225^7
 ;;^UTILITY(U,$J,358.3,18958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18958,1,4,0)
 ;;=4^112.0
 ;;^UTILITY(U,$J,358.3,18958,1,5,0)
 ;;=5^Candidiasis, Oral
 ;;^UTILITY(U,$J,358.3,18958,2)
 ;;=^18599
 ;;^UTILITY(U,$J,358.3,18959,0)
 ;;=366.9^^105^1225^9
 ;;^UTILITY(U,$J,358.3,18959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18959,1,4,0)
 ;;=4^366.9
 ;;^UTILITY(U,$J,358.3,18959,1,5,0)
 ;;=5^Cataract NOS
 ;;^UTILITY(U,$J,358.3,18959,2)
 ;;=^20266
 ;;^UTILITY(U,$J,358.3,18960,0)
 ;;=380.4^^105^1225^10
 ;;^UTILITY(U,$J,358.3,18960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18960,1,4,0)
 ;;=4^380.4
 ;;^UTILITY(U,$J,358.3,18960,1,5,0)
 ;;=5^Cerumen Impacton
 ;;^UTILITY(U,$J,358.3,18960,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,18961,0)
 ;;=372.72^^105^1225^12
 ;;^UTILITY(U,$J,358.3,18961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18961,1,4,0)
 ;;=4^372.72
 ;;^UTILITY(U,$J,358.3,18961,1,5,0)
 ;;=5^Conjunctival Hemorrhage
 ;;^UTILITY(U,$J,358.3,18961,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,18962,0)
 ;;=372.30^^105^1225^13
 ;;^UTILITY(U,$J,358.3,18962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18962,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,18962,1,5,0)
 ;;=5^Conjunctivitis NOS
 ;;^UTILITY(U,$J,358.3,18962,2)
 ;;=^27546
 ;;^UTILITY(U,$J,358.3,18963,0)
 ;;=918.1^^105^1225^14
 ;;^UTILITY(U,$J,358.3,18963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18963,1,4,0)
 ;;=4^918.1
 ;;^UTILITY(U,$J,358.3,18963,1,5,0)
 ;;=5^Corneal Abrasion
 ;;^UTILITY(U,$J,358.3,18963,2)
 ;;=^115829
 ;;^UTILITY(U,$J,358.3,18964,0)
 ;;=784.7^^105^1225^22
 ;;^UTILITY(U,$J,358.3,18964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18964,1,4,0)
 ;;=4^784.7
 ;;^UTILITY(U,$J,358.3,18964,1,5,0)
 ;;=5^Nosebleed
 ;;^UTILITY(U,$J,358.3,18964,2)
 ;;=Nosebleed^41658
 ;;^UTILITY(U,$J,358.3,18965,0)
 ;;=365.9^^105^1225^16
 ;;^UTILITY(U,$J,358.3,18965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18965,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,18965,1,5,0)
 ;;=5^Glaucoma NOS
 ;;
 ;;$END ROU IBDEI12Q
